Fibroblast growth factor 23 and cardiovascular mortality after kidney transplantation - Wikidata - wikimedia - TriplyDB

Fibroblast growth factor 23 and cardiovascular mortality after kidney transplantation

Fibroblast growth factor 23 and cardiovascular mortality after kidney transplantation

http://www.wikidata.org/entity/Q37280819

about

Mineral and bone disorder after kidney transplantation Vitamin D in renal transplantation - from biological mechanisms to clinical benefits Antidepressants differentially related to 1,25-(OH)₂ vitamin D₃ and 25-(OH) vitamin D₃ in late-life depression.Impact of seasonality on the dynamics of native Vitamin D repletion in long-term renal transplant patients The use of fibroblast growth factor 23 testing in patients with kidney disease.Relation between Red Cell Distribution Width and Fibroblast Growth Factor 23 Cleaving in Patients with Chronic Kidney Disease and Heart Failure Calcification Propensity and Survival among Renal Transplant Recipients.Fibroblast growth factor-23 and chronic allograft injury in pediatric renal transplant recipients: a Midwest Pediatric Nephrology Consortium study.Plasma Fibroblast Growth Factor 23: Clinical Correlates and Association With Cardiovascular Disease and Mortality in the Framingham Heart Study.Response of fibroblast growth factor 23 to volume interventions in arterial hypertension and diabetic nephropathy.Roles of phosphate and fibroblast growth factor 23 in cardiovascular disease.Vitamin D: a new player in kidney transplantation?Dietary sodium restriction: a neglected therapeutic opportunity in chronic kidney disease.Bone kidney interactions.The Kidney-Vascular-Bone Axis in the Chronic Kidney Disease-Mineral Bone Disorder.Phosphate and FGF-23 homeostasis after kidney transplantation.Post-Transplant Hypophosphatemia and the Risk of Death-Censored Graft Failure and Mortality after Kidney Transplantation.Fibroblast Growth Factor 23: Mineral Metabolism and Beyond.Hyperparathyroidism and increased fractional excretion of phosphate predict allograft loss in long-term kidney transplant recipients.Extrarenal effects of FGF23.C-Terminal Fibroblast Growth Factor 23, Iron Deficiency, and Mortality in Renal Transplant Recipients.Fibroblast growth factor 23 correlates with volume status in haemodialysis patients and is not reduced by haemodialysis.FGF23 in kidney transplant: the strange case of Doctor Jekyll and Mister Hyde.The fibroblast growth factor-23 and Vitamin D emerge as nontraditional risk factors and may affect cardiovascular risk.Effect of Omega-3 Fatty Acid Supplementation on Plasma Fibroblast Growth Factor 23 Levels in Post-Myocardial Infarction Patients with Chronic Kidney Disease: The Alpha Omega Trial.The Association Between Fibroblast Growth Factor 23 and Renal Transplantation Outcome Is Modified by Follow-up Duration and Glomerular Filtration Rate Assessment Method.Long-Term Progression of Coronary Artery Calcification Is Independent of Classical Risk Factors, C-Reactive Protein, and Parathyroid Hormone in Renal Transplant Patients.Tubular maximum phosphate reabsorption capacity in living kidney donors is independently associated with one-year recipient GFR.Evaluation of a New Fully Automated Assay for Plasma Intact FGF23.Baseline FGF23 is Associated with Cardiovascular Outcome in Incident PD Patients.Plasma levels of marine n-3 fatty acids and cardiovascular risk markers in renal transplant recipients.Membrane-bound Klotho is not expressed endogenously in healthy or uraemic human vascular tissue.Paracrine Effects of FGF23 on the Heart.Uremic Toxins and Clinical Outcomes: The Impact of Kidney Transplantation.

P2860

Q26771398-C7B6FFF7-3BDF-43BC-BAC9-BC2240EC8C6C Q27026932-B51F468D-8A7F-40E7-869C-2BE0D52A9F4E Q33574994-8D59A8B8-6A7E-4B46-A6E0-A7F3DD87C5AD Q33783035-DFC0B313-0ECA-484A-80EC-95F6382F83C7 Q33835743-E3BDBF1B-FA19-4636-A48C-65CDE3C8F2EF Q35665003-5DBBBF97-1B8B-4997-B32D-FBD86DEF42A9 Q36417860-94E8D547-91C6-4690-BC68-CEAAB9912674 Q36759150-3149BF0C-A01A-4261-A9A2-96108AF146AE Q37240698-B58E3974-F0ED-4E2B-9F89-3605645013F9 Q37432867-72A90BB4-16A2-4507-A854-DB802D929AEC Q38200883-E7C79EC6-17DC-4C7A-9470-061B7C82CA5C Q38241062-80DFA327-5519-4D04-8135-B72D71446081 Q38249494-F0F3D209-2E77-4B08-9D1D-CED168DB1FEC Q38544166-B7625479-97A1-4923-ADFB-BBCB2BE57072 Q38584122-25323739-B740-4311-B0DB-BD8C101D34FA Q38594874-90A55FCA-369C-47C6-9EEE-8366DA4618DA Q38762820-43572C54-2760-47B1-851A-0F4181D30D69 Q38768746-26B1C099-211B-4BE1-AD1A-505C0A7C7331 Q38782222-ACD746F6-74A0-4FEA-BF40-6E56F446A90E Q38972469-DB0CFF90-F2FB-405B-9A5D-E341218A65D1 Q40095461-3A0D0AA6-E289-42C3-8889-5DA25250BD1C Q40279706-4AB5F7A1-BE81-47DE-9025-167D2149C0F9 Q41186366-12E6DD6E-FF3D-47DF-BA11-2F4B4AAACEFB Q45134043-C7887F68-4935-439C-8BCB-E1204DBE36DD Q47134765-6B4EA2E7-331B-4835-AEA5-0CE45BFD2D0E Q47151319-CF360089-414E-426B-991B-685ABEE3A97D Q47423230-60E68152-313B-4417-B153-243E7519CE7E Q47863864-C899A149-A39F-43AD-AD0F-144ACC1770BF Q48316515-741F79BD-3E4E-42D3-B3E3-ECEC95023E48 Q50636871-0C43B28B-1D5B-4F02-B820-73F79B3F8C92 Q51287889-56E61ADC-2958-49F8-8476-166662A9ABB7 Q52934731-1D412442-25F1-48AF-93D9-C65DD94586AA Q55221465-835BECD8-BDF5-4B5E-B71A-5976BACD346E Q55496554-A3FC63F8-E4A0-48F0-806D-6F1835F48B11

P2860

Fibroblast growth factor 23 and cardiovascular mortality after kidney transplantation

http://www.wikidata.org/entity/Q37280819

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 08 August 2013

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Fibroblast growth factor 23 and cardiovascular mortality after kidney transplantation

@en

Fibroblast growth factor 23 and cardiovascular mortality after kidney transplantation.

@nl

type

label

Fibroblast growth factor 23 and cardiovascular mortality after kidney transplantation

@en

Fibroblast growth factor 23 and cardiovascular mortality after kidney transplantation.

@nl

prefLabel

Fibroblast growth factor 23 and cardiovascular mortality after kidney transplantation

@en

Fibroblast growth factor 23 and cardiovascular mortality after kidney transplantation.

@nl

P1433

Q37280819-0411E9A9-69B4-4689-A153-EA81DC6F6B51

P1476

Q37280819-71D5CE14-1986-4E7D-8BBB-909D1A585D65

P2093

Q37280819-471926AE-DC72-487D-8FD5-A727216B17B1

Q37280819-584ACDFD-9653-4736-B925-80D262ACD428

Q37280819-608E2CBE-F2BB-4DB0-9D27-06BD4F702ED8

Q37280819-7A5B88F5-B196-4B48-8C9A-256C2BEE4BB5

Q37280819-81372DBF-554A-4BE4-86A9-E77EF3C19243

Q37280819-E5FA610F-F800-45BF-ACF4-6EBE9DA212F5

Q37280819-EF4F481C-4122-4298-BCBA-9B8EB3DED88B

P2860

Q37280819-05B9ECCF-957A-4A90-AA42-85C8AC60B8F3

Q37280819-0DE15871-25D6-41DD-B9C5-8E60AA938CA7

Q37280819-1175B2BB-E957-4475-8901-52CFFF631512

Q37280819-131338BC-4C12-43A3-AFC3-AB37849940C3

Q37280819-15206439-F8C7-419D-B7EB-ED94960AD519

Q37280819-19F69956-1055-4814-BB59-1319E6FFA677

Q37280819-2C0DA45C-BB7C-4CA3-B0BD-358B55EEC66B

Q37280819-2F52BFA6-0012-4C06-9832-9E2A77543B04

Q37280819-33C50EC4-6E0A-45C1-88F9-14940D6DF966

Q37280819-54ABAB1B-8905-4651-85FA-B02FE4B83326

P304

Q37280819-750324C2-C4E3-471F-841A-692C526A1D57

P31

Q37280819-94094104-8155-4D90-B7E8-AE05F716A334

P356

Q37280819-404DBAC4-6CD7-4064-B0B5-521D67D2DB86

P433

Q37280819-303FFB6C-D5A4-4614-BA9D-85466E081078

P478

Q37280819-52145727-0972-49E4-8061-EE213546EFDF

P577

Q37280819-112F4AD7-576B-4D58-A3A2-D362B38EFF08

P698

Q37280819-00AAE461-FC3C-4D6C-A63A-7B305CA8D32E

P921

Q37280819-7A457B8E-ADF5-49FB-BFDF-AD9FEF29FC9B

P932

Q37280819-81EE99F6-0897-4BEA-9F0A-2B392779E4AC

P356

P1433

Clinical Journal of the American Society of Nephrology

P1476

Fibroblast growth factor 23 and cardiovascular mortality after kidney transplantation

@en

P2093

Gerjan Navis

http://www.w3.org/2001/XMLSchema#string

Jelmer K Humalda

http://www.w3.org/2001/XMLSchema#string

Leandro C Baia

http://www.w3.org/2001/XMLSchema#string

Marc G Vervloet

http://www.w3.org/2001/XMLSchema#string

Martin H de Borst

http://www.w3.org/2001/XMLSchema#string

NIGRAM Consortium

http://www.w3.org/2001/XMLSchema#string

Stephan J L Bakker

http://www.w3.org/2001/XMLSchema#string

P2860

A new equation to estimate glomerular filtration rate

Evaluating the added predictive ability of a new marker: from area under the ROC curve to reclassification and beyond

Elevated fibroblast growth factor 23 is a risk factor for kidney transplant loss and mortality.

Fibroblast growth factor 23 and mortality among patients undergoing hemodialysis

Circulating concentration of FGF-23 increases as renal function declines in patients with chronic kidney disease, but does not change in response to variation in phosphate intake in healthy volunteers.

Fibroblast growth factor 23 and left ventricular hypertrophy in chronic kidney disease.

FGF23 induces left ventricular hypertrophy

Evaluation of multiple biomarkers of cardiovascular stress for risk prediction and guiding medical therapy in patients with stable coronary disease.

Fibroblast growth factor 23 is associated with proteinuria and smoking in chronic kidney disease: an analysis of the MASTERPLAN cohort.

The evolving concept of the healthy worker survivor effect.

P304

1968-1978

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2215/CJN.01880213

http://www.w3.org/2001/XMLSchema#string

P433

11

http://www.w3.org/2001/XMLSchema#string

P478

8

http://www.w3.org/2001/XMLSchema#string

P577

2013-08-08T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

23929933

http://www.w3.org/2001/XMLSchema#string

P921

Aparato circulatorio

P932

3817902

http://www.w3.org/2001/XMLSchema#string